(Q22242870)

English

Parkinson's disease: from monogenic forms to genetic susceptibility factors

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Parkinson's disease: from monogenic forms to genetic susceptibility factors (English)

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

S. Lesage

1

author given names

Suzanne

author last names

Lesage

1 reference

PubMed publication ID

28 March 2023

A. Brice

2

author given names

Alexis

author last names

Brice

1 reference

PubMed publication ID

28 March 2023

language of work or name

0 references

publication date

15 April 2009

0 references

Human Molecular Genetics

0 references

18

0 references

R1

0 references

R48-R59

0 references

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Present and future drug treatment for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Alpha-synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

alpha-Synuclein gene duplication is present in sporadic Parkinson disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genomic investigation of alpha-synuclein multiplication and parkinsonism

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Prominent psychiatric symptoms and glucose hypometabolism in a family with a SNCA duplication

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

G2019S LRRK2 mutation in French and North African families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genetic screening of the G2019S mutation of the LRRK2 gene in Southwest European, North African, and Sephardic Jewish subjects

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Absence/rarity of commonly reported LRRK2 mutations in Indian Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

PARK9-LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Significant linkage of Parkinson disease to chromosome 2q36-37

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Lack of replication of association between GIGYF2 variants and Parkinson disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genetic variation of Omi/HtrA2 and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

A susceptibility gene for late-onset idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Neurodegeneration associated with genetic defects in phospholipase A(2).

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genetic anticipation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

SCA2 may present as levodopa-responsive parkinsonism

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: clinical implications.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Analysis of SCA-2 and SCA-3 repeats in Parkinsonism: evidence of SCA-2 expansion in a family with autosomal dominant Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The parkinsonian phenotype of spinocerebellar ataxia type 2.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Multiple regions of alpha-synuclein are associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

alpha-Synuclein promoter confers susceptibility to Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Growth hormone treatment in short Japanese children born small for gestational age.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Interface between tauopathies and synucleinopathies: A tale of two proteins

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

LRRK2 Gly2385Arg variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Essential tremor and the common LRRK2 G2385R variant

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Analysis of the LRRK2 Gly2385Arg variant in primary dystonia and multiple system atrophy in Taiwan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Lrrk2 R1628P in non-Chinese Asian races

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Glucocerebrosidase mutations in subjects with parkinsonism

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Analysis of the glucocerebrosidase gene in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

New genetic insights into Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Neuropathology provides clues to the pathophysiology of Gaucher disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

High-resolution whole-genome association study of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Considerations for genomewide association studies in Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genomewide association study for susceptibility genes contributing to familial Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

The Ala53Thr mutation in the α-synuclein gene in a Korean family with Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Lrrk2 pathogenic substitutions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

LRRK2 mutations in Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Are interruptedSCA2CAG repeat expansions responsible for parkinsonism?

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

alpha-synuclein gene haplotypes are associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

-Synuclein, pesticides, and Parkinson disease: A case-control study

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

LRRK2 mutation in familial Parkinson’s disease in a Taiwanese population: clinical, PET, and functional studies

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

LRRK2G2019S as a Cause of Parkinson's Disease in North African Arabs

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

21 January 2018

Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr ?-synuclein mutation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing LRRK2 Gly2385Arg carriers with noncarriers

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese Asians

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

The utility F-box for protein destruction

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

LRRK2 R1628P increases risk of Parkinson's disease: replication evidence

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between Parkinson's disease and glucocerebrosidase mutations in Brazil

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropathology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurological signs: Behçet's disease, coeliac disease, both, or neither?

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-motor symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of LRRK2 G2019S penetrance: Relevance for genetic counseling in Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDP012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22242870&oldid=1863428555"